CatSci wins Welsh grant for oligonucleotides development

GBP pound sterling funding

CatSci has won a Welsh Government SMART Capital Equipment Fund grant to enhance its oligonucleotides capability.

The grant will enable the company to invest in new equipment that will increase the rapid creation of a large pool of candidates of RNA/DNA sequences.

Production of oligonucleotides is currently both slow and expensive, meaning the development of new sequences tends to focus on producing small numbers of specific sequences only. These represent a high level of risk due to the high probability of failure.

Using the grant, CatSci will develop a novel screening approach, which allows a very large pool of candidates to be screened against the drug target. The company hopes this will increase the chance of success and decrease the impact on the environment.

The SMART Flexible Innovation Support grant was rewarded to support companies in Wales to invest in innovation with the aim of improving people’s lives, growing the economy, and addressing the climate and nature emergencies.

Diana Spencer, Senior Digital Content Editor, DDW

Related Articles

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free